BioSpace News Archive

Business

AngioDynamics Reports Fiscal 2020 First Quarter Financial Results

AngioDynamics, Inc. announced financial results for the first quarter of fiscal year 2020, which ended August 31, 2019.

October 3, 2019
·
15 min read
Bio NC

Milestone Pharmaceuticals Announces First Patient Enrolled in NODE-303 Open-label Safety Study of Etripamil in PSVT

Milestone Pharmaceuticals Inc. announced that the first patient has been enrolled in the Phase 3 NODE-303 study.

October 3, 2019
·
5 min read
Drug Development

Soligenix to Present at the 20th Annual GCFF Investor Conference in Vancouver, British Columbia, Canada

Review of Two Phase 3 Clinical Programs with Near-Term Readouts

October 3, 2019
·
5 min read
Deals

Turn Therapeutics™ Closes Series B Round to Fuel Lead Atopic Dermatitis Program Trial and Pipeline Expansion

Turn Therapeutics™, Inc., a Los Angeles-based pharmaceutical and medical device company, has announced the closing of its fully-subscribed series B financing.

October 3, 2019
·
2 min read
Policy

Biofourmis’ Biovitals™ Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring

Milestone approval establishes AI-powered solution as the foundation for future disease-specific predictive management tools from Biofourmis

October 3, 2019
·
6 min read
Genetown

How to Practice Better Dentistry: Free CE Webinar by Dr. Susan McMahon

Dentist and Educator Presents the Latest Trends in Digital Diagnostics and Bioactive Materials

October 3, 2019
·
2 min read
BioMidwest

BacterioScan To Announce Disruptive Approach For Rapid Identification Of Pathogens That Cause Infectious Disease In Humans At IDWeek

BacterioScan’s versatile infectious disease diagnostic platform will combine pathogen detection, identification, and antimicrobial susceptibility testing into a fast, accurate and affordable test

October 3, 2019
·
2 min read
Job Trends

Studies Confirm Rapid Phenotypic Susceptibility Results Enable Earlier Antimicrobial Intervention and Better Patient Outcomes

From IDWeek™, the annual meeting of the Infectious Diseases Society of America (IDSA) held in Washington, DC October 2 - 6.

October 3, 2019
·
7 min read
Business

Akero Therapeutics and InSphero partner to evaluate AKR-001 using InSphero’s 3D InSight™ Human Liver Disease platform

3D InSight™ Human Liver Disease Platform will be used to screen effects of Akero lead program AKR-001 on underlying metabolic and fibrotic drivers of NAFLD and NASH.

October 3, 2019
·
5 min read
Drug Development

Verastem Oncology Presents New Preclinical Duvelisib Data at the 5th International Conference on New Concepts in Lymphoid Malignancies

Duvelisib’s Dual Inhibition of PI3K-Delta and PI3K-Gamma Inhibits Migration and Proliferation of Mantle Cell Lymphoma Cells More Effectively Than PI3K-Delta Alone in Preclinical Models

October 3, 2019
·
8 min read